netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Cisplatin found 10 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Cisplatin Malignant disease and immunosuppression - Platinum compounds - 08.01.05
  Cytotoxic Drug Atezolizumab Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Cytotoxic Drug Durvalumab  (Imfinzi®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Cytotoxic Drug Paclitaxel - Albumin Bound Formulation  (Abraxane®) Malignant disease and immunosuppression - Taxanes - 08.01.05
  Cytotoxic Drug Pemetrexed Malignant disease and immunosuppression - Antimetabolites - 08.01.03
 
Non Formulary BNF Category
  Pembrolizumab  (Keytruda®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA402: Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin (08.01.03)
link in drug section NICE TA739: Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable (08.01.05)
link in drug section NICE TA944: Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer (08.01.05)
link in drug section NICE TA966: Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal) (08.01.05)


 
netFormulary